{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:35:40Z","timestamp":1785173740241,"version":"3.55.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["24QB2700300"],"award-info":[{"award-number":["24QB2700300"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22077034"],"award-info":[{"award-number":["22077034"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104000"],"award-info":[{"award-number":["82104000"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejmech.2025.117512","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:06:57Z","timestamp":1741997217000},"page":"117512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Design, synthesis and biological evaluation of WEE1 degraders via HSP90-mediated targeting chimeras for target therapy of acute myeloid leukemia"],"prefix":"10.1016","volume":"290","author":[{"given":"Xiaomei","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minmin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialuo","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangying","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingkun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ejmech.2025.117512_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104178","article-title":"Targeted protein degradation: current molecular targets, localization, and strategies","volume":"29","author":"Pliatsika","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.ejmech.2025.117512_bib2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/d41573-024-00187-0","article-title":"The targeted protein degradation landscape","volume":"24","author":"Farley","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"issue":"15","key":"10.1016\/j.ejmech.2025.117512_bib3","doi-asserted-by":"crossref","first-page":"10183","DOI":"10.1021\/acs.jmedchem.2c00691","article-title":"Targeting undruggable transcription factors with PROTACs: advances and perspectives","volume":"65","author":"Li","year":"2022","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117512_bib4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1021\/acsmedchemlett.2c00479","article-title":"Development of oligomeric mannose-6-phosphonate conjugates for targeted protein degradation","volume":"14","author":"Stevens","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117512_bib5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/jacs.0c10008","article-title":"Development of antibody-based PROTACs for the degradation of the cell-surface immune checkpoint protein PD-L1","volume":"143","author":"Cotton","year":"2021","journal-title":"J. Am. Chem. Soc."},{"issue":"16","key":"10.1016\/j.ejmech.2025.117512_bib6","doi-asserted-by":"crossref","first-page":"12273","DOI":"10.1021\/acs.jmedchem.1c00901","article-title":"Folate-guided protein degradation by immunomodulatory imide drug-based molecular glues and proteolysis targeting chimeras","volume":"64","author":"Chen","year":"2021","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117512_bib7","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/bph.15014","article-title":"Proteolysis-targeting chimeras in drug development: a safety perspective","volume":"177","author":"Moreau","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"27","key":"10.1016\/j.ejmech.2025.117512_bib8","doi-asserted-by":"crossref","first-page":"18473","DOI":"10.1074\/jbc.R800007200","article-title":"The Hsp90 chaperone machinery","volume":"283","author":"Wandinger","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117512_bib9","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1021\/acs.jmedchem.2c01648","article-title":"Targeted protein degradation induced by HEMTACs based on HSP90","volume":"66","author":"Li","year":"2023","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117512_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.161","article-title":"Heat shock proteins: biological functions, pathological roles, and therapeutic opportunities","volume":"3","author":"Hu","year":"2022","journal-title":"Medcomm"},{"key":"10.1016\/j.ejmech.2025.117512_bib11","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.biochi.2016.05.018","article-title":"Hsp90: friends, clients and natural foes","volume":"127","author":"Verma","year":"2016","journal-title":"Biochimie"},{"issue":"10","key":"10.1016\/j.ejmech.2025.117512_bib12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrc1716","article-title":"HSP90 and the chaperoning of cancer","volume":"5","author":"Whitesell","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2025.117512_bib13","first-page":"89","article-title":"Hsp90 in cancer: transcriptional roles in the nucleus","volume":"vol. 129","author":"Calderwood","year":"2016"},{"issue":"7","key":"10.1016\/j.ejmech.2025.117512_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/biom12070911","article-title":"Extracellular heat shock protein-90 (eHsp90): everything you need to know","volume":"12","author":"Jay","year":"2022","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117512_bib15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1021\/acschembio.7b00006","article-title":"A fluorescent Hsp90 probe demonstrates the unique association between extracellular Hsp90 and malignancy in vivo<\/i&gt","volume":"12","author":"Crowe","year":"2017","journal-title":"ACS Chem. Biol."},{"issue":"39","key":"10.1016\/j.ejmech.2025.117512_bib16","doi-asserted-by":"crossref","first-page":"16363","DOI":"10.1073\/pnas.1108372108","article-title":"Heat shock protein 90 (HSP90) contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cells","volume":"108","author":"Imai","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"10","key":"10.1016\/j.ejmech.2025.117512_bib17","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1021\/acs.jmedchem.0c00305","article-title":"Design, synthesis, and biological evaluation of HSP90 inhibitor-SN38 conjugates for targeted drug accumulation","volume":"63","author":"Zhu","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117512_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110310","article-title":"The expanding role of WEE1","volume":"94","author":"Koh","year":"2022","journal-title":"Cell. Signal."},{"issue":"24","key":"10.1016\/j.ejmech.2025.117512_bib19","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1242\/jcs.00908","article-title":"Wee1-dependent mechanisms required for coordination of cell growth and cell division","volume":"116","author":"Kellogg","year":"2003","journal-title":"J. Cell Sci."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117512_bib20","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.tips.2016.06.006","article-title":"Targeting WEE1 kinase in cancer","volume":"37","author":"Matheson","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"issue":"16","key":"10.1016\/j.ejmech.2025.117512_bib21","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1158\/1078-0432.CCR-17-0520","article-title":"Molecular pathways: targeting the protein kinase Wee1 in cancer","volume":"23","author":"Geenen","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.117512_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2020.06.009","article-title":"A phase II trial of the Wee1 inhibitor adavosertib (AZD1775) in recurrent uterine serous carcinoma","volume":"159","author":"Liu","year":"2020","journal-title":"Gynecol. Oncol."},{"issue":"16","key":"10.1016\/j.ejmech.2025.117512_bib23","article-title":"A phase 2 study of the WEE1 inhibitor AZD1775 in SETD2-deficient advanced solid tumor malignancies","volume":"41","author":"Maldonado","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117512_bib24","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1158\/1078-0432.CCR-19-3470","article-title":"Phase I clinical trial of the Wee1 inhibitor adavosertib (AZD1775) with irinotecan in children with relapsed solid tumors: a cog phase I consortium report (ADVL1312)","volume":"26","author":"Cole","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"30","key":"10.1016\/j.ejmech.2025.117512_bib25","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1200\/JCO.2014.60.4009","article-title":"Phase I study of single-agent AZD1775 (MK-1775), a Wee1 kinase inhibitor, in patients with refractory solid tumors","volume":"33","author":"Do","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.ejmech.2025.117512_bib26","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1158\/1078-0432.CCR-21-0329","article-title":"Safety, antitumor activity, and biomarker analysis in a phase I trial of the once-daily Wee1 inhibitor adavosertib (AZD1775) in patients with advanced solid tumors","volume":"27","author":"Takebe","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.117512_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128636","article-title":"Selective Wee1 degradation by PROTAC degraders recruiting VHL and CRBN E3 ubiquitin ligases","volume":"64","author":"Aublette","year":"2022","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2025.117512_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114786","article-title":"Design, synthesis, and biological evaluation of Wee1 kinase degraders","volume":"243","author":"Zhu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117512_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.chembiol.2019.10.013","article-title":"Development and characterization of a Wee1 kinase degrader","volume":"27","author":"Li","year":"2020","journal-title":"Cell Chem. Biol."},{"issue":"46","key":"10.1016\/j.ejmech.2025.117512_bib30","doi-asserted-by":"crossref","first-page":"31433","DOI":"10.1021\/jacs.4c06127","article-title":"Discovery of CRBN-dependent WEE1 molecular glue degraders from a multicomponent combinatorial library","volume":"146","author":"Razumkov","year":"2024","journal-title":"J. Am. Chem. Soc."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117512_bib31","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1021\/acs.jmedchem.9b00940","article-title":"Heat shock protein 90 inhibitors: an update on achievements, challenges, and future directions","volume":"63","author":"Li","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.117512_bib32","series-title":"Hsp90-binding Conjugates and Formulations Thereof","author":"White","year":"2022"},{"key":"10.1016\/j.ejmech.2025.117512_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.dyepig.2021.109783","article-title":"An HSP90 inhibitor based fluorescent probe for selective tumor targeting","volume":"196","author":"Zhu","year":"2021","journal-title":"Dyes Pigments"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425002776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:22:57Z","timestamp":1745454177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425002776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":33,"alternative-id":["S0223523425002776"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117512","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis and biological evaluation of WEE1 degraders via HSP90-mediated targeting chimeras for target therapy of acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117512"}}